Therefore, while PI3K inhibitors may be a promising therapeutic option for alleviating neuroinflammation and cognitive decline, their efficacy may be limited against key pathological mechanisms such as Aβ accumulation and neuronal damage. Here, PIK3CD is linked to Mental deterioration.